Targeting GPNMB with glembatumumab vedotin: Current developments and future opportunities for the treatment of cancer

Document Details

Document Type
Pub Defense Publication
Publication Date
Nov 01, 2017
Source ID
10.1016/j.pharmthera.2017.05.010

Entities

People

  • April A.n. Rose
  • Marco Biondini
  • Peter M. Siegel
  • Rafael Curiel

Organizations

  • Canadian Institutes of Health Research
  • Celldex Therapeutics
  • Fonds de Recherche du Québec Santé
  • McGill University
  • United States Department of Defense